Total Payments
$3,235
2024 Payments
$426.58
Companies
35
Transactions
214
Medicare Patients
2,435
Medicare Billing
$583,353
Payment Breakdown by Category
Food & Beverage$3,162 (97.7%)
Other$66.01 (2.0%)
Education$6.96 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,162 | 210 | 97.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66.01 | 3 | 2.0% |
| Education | $6.96 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $673.74 | 46 | $0 (2024) |
| Allergan, Inc. | $314.37 | 24 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $297.44 | 15 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $196.41 | 16 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $187.88 | 24 | $0 (2021) |
| PFIZER INC. | $154.43 | 21 | $0 (2023) |
| Stryker Corporation | $140.82 | 2 | $0 (2022) |
| UCB, Inc. | $126.78 | 7 | $0 (2018) |
| Medtronic, Inc. | $124.06 | 5 | $0 (2024) |
| Penumbra, Inc. | $121.46 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $426.58 | 16 | ABBVIE INC. ($232.68) |
| 2023 | $554.81 | 46 | AbbVie Inc. ($173.94) |
| 2022 | $439.58 | 28 | ABBVIE INC. ($208.68) |
| 2021 | $307.51 | 30 | Biohaven Pharmaceuticals, Inc. ($172.24) |
| 2020 | $160.24 | 9 | Biogen, Inc. ($47.75) |
| 2019 | $346.84 | 13 | Penumbra, Inc. ($121.46) |
| 2018 | $915.54 | 66 | Allergan Inc. ($146.79) |
| 2017 | $84.20 | 6 | Allergan Inc. ($40.86) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $115.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/09/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Central Nervous System | ||||||
| 06/28/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Central Nervous System | ||||||
| 06/10/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $28.96 | General |
| Category: Diagnostic Tracer | ||||||
| 05/16/2024 | ABBVIE INC. | BOTOX (Biological), UBRELVY | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Central Nervous System | ||||||
| 04/05/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 04/03/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Central Nervous System | ||||||
| 03/07/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Central Nervous System | ||||||
| 12/06/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: PAIN | ||||||
| 12/06/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: PAIN | ||||||
| 12/01/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2023 | AbbVie Inc. | BOTOX (Biological), UBRELVY | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/07/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: PAIN | ||||||
| 10/27/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Central Nervous System | ||||||
| 10/25/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 585 | 16,490 | $342,495 | $158,634 |
| 2022 | 8 | 629 | 14,312 | $324,210 | $153,916 |
| 2021 | 10 | 609 | 13,321 | $304,040 | $145,165 |
| 2020 | 10 | 612 | 13,449 | $294,229 | $125,638 |
Total Patients
2,435
Total Services
57,572
Medicare Billing
$583,353
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 28 | 15,660 | $187,920 | $77,568 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 295 | 496 | $74,400 | $41,969 | 56.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 126 | 126 | $34,650 | $19,726 | 56.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 18 | 53 | $13,250 | $5,600 | 42.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 37 | 74 | $12,950 | $5,504 | 42.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 25 | $4,750 | $3,154 | 66.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 16 | 16 | $7,200 | $2,132 | 29.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 15 | 15 | $4,875 | $1,535 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 25 | $2,500 | $1,446 | 57.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 22 | 13,430 | $161,160 | $65,493 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 310 | 527 | $79,050 | $45,839 | 58.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 170 | 170 | $46,825 | $25,358 | 54.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 40 | $7,600 | $4,896 | 64.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 34 | 62 | $10,850 | $4,802 | 44.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 13 | 41 | $10,250 | $4,230 | 41.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 19 | 19 | $6,175 | $1,909 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 23 | $2,300 | $1,390 | 60.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 21 | 12,470 | $145,760 | $58,261 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 288 | 490 | $73,500 | $43,288 | 58.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 131 | 131 | $36,175 | $21,364 | 59.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 57 | $10,830 | $7,149 | 66.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 39 | 71 | $12,425 | $5,546 | 44.6% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 14 | 39 | $9,750 | $4,025 | 41.3% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 18 | 18 | $8,100 | $2,522 | 31.1% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 15 | 15 | $4,875 | $1,694 | 34.8% |
About Dr. Eric Drew, M.D
Dr. Eric Drew, M.D is a Neurology healthcare provider based in Flower Mound, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578539839.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Drew, M.D has received a total of $3,235 in payments from pharmaceutical and medical device companies, with $426.58 received in 2024. These payments were reported across 214 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,162).
As a Medicare-enrolled provider, Drew has provided services to 2,435 Medicare beneficiaries, totaling 57,572 services with total Medicare billing of $583,353. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Flower Mound, TX
- Active Since 02/27/2006
- Last Updated 06/22/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1578539839
Products in Payments
- BOTOX (Biological) $481.46
- NURTEC ODT (Drug) $342.31
- NUPLAZID (Drug) $196.41
- UBRELVY (Drug) $150.61
- PROPHECY (Device) $140.82
- PERCEPT PC BRAINSENSE (Device) $124.06
- BOTOX THERAPEUTIC (Biological) $122.01
- Penumbra System (Device) $121.46
- Austedo XR (Drug) $106.63
- QULIPTA (Drug) $98.71
- AJOVY (Drug) $86.82
- DUOPA (Drug) $69.68
- APTIOM (Drug) $66.58
- AJOVY (Biological) $66.21
- Gamunex-C (Biological) $61.45
- Neupro (Drug) $51.87
- Briviact (Drug) $51.57
- AVONEX (Biological) $47.75
- INBRIJA (Drug) $44.27
- NAMZARIC (Drug) $38.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.